Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie
Recruiting · NCT07357311 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →What this trial is about
The goals of this study is to establish the prevalence of severe forms of FCR in the oncology hospital setting, which will require a specific psychotherapeutic response. Two cancer sites are targeted: breast and pulmonary cancers. Secondary objectives include: 1) Determining threshold scores for the FCRI's 9-item severity scale for each type of cancer; 3) To identify a simple item from the FCRI for early detection of FCR in everyday clinical practice, especially using a digital format.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Aged 18 or over
- Clinical or pathological diagnosis of primary or recurrence of a localized/loco-regional or metastatic breast cancer, or a stage 1 or 2, or stage 3 or 4 lung cancer; or a breast or lung cancer metastatic progression
- Three months after completing treatment or three months after the start of a first treatment line for metastatic progression
- Able to comply with the scheduled assessment and interviews
- Able to read and understand the questionnaires' language (i.e. French)
Exclusion criteria
- Participating in another patient-reported outcome study interfering with the present study
- Any social, medical or psychological condition hindering questionnaire completion
- Being deprived of personal liberty or under guardianship
Where it is running
2 locations listed.
- Institut Curie - Paris, France
- Institut Curie - Paris, France